So-Young International (ADR)
Connects medical-aesthetics information, reservations, branded centers, and supply-chain services in China.
Something off on this page? Send us feedback.
Profile
Provides information, community content, and offline reservations for medical-aesthetic treatments in China. The model combines an online platform with branded aesthetic centers and medical-product supply-chain services.
Connects people considering medical-aesthetic treatments with information, community content, and offline reservations in China. Information and reservation services remain the core of its online platform, which began as a place to research treatments and share experiences.
Combines that platform with branded aesthetic-treatment centers and supply-chain services for medical equipment and injectable products, extending its role across more of the treatment journey. Operations depend on digital-platform execution as well as the clinical, regulatory, and operating requirements of its offline network. The Cayman issuer uses contractual arrangements with affiliated entities in China.
Company facts
Key statistics
Analysts
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Target |
|---|---|---|---|---|---|
| Jul 8, 2025 | Citigroup | Upgrade | Neutral | Buy | |
| Sep 23, 2024 | Citigroup | Downgrade | Buy | Neutral | $0.80 |
Earnings
EPSReportedEstimate
RevenueReportedEstimate
Financials
Balance sheet, Jun 30, 2026Cash & short-term investments $126.2M · Total debt $56.3M · Total assets $398.7M · Shareholders' equity $217.4M
- Revenue
- $75.0M
- Operating income
- −$6.5M
- Net income
- −$3.4M
Reported in CNY, converted at the latest exchange rate
Dividends
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Apr 8, 2025 | Apr 8 | Apr 25 | $0.0265 | special dividend |
| Apr 11, 2024 | Apr 12 | Apr 29 | $0.06 |
Ownership
| Institutions35 holders · as of Mar 31, 2026 | 21.69% | 28.46M ADS | |
| Otherremainder | 78.31% | 102.75M ADS |
131.21M ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
This company has 3 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
TB Alternative Assets Ltd.Institution | 7.01% | 3.07M A ADS · 3.07M A ADS · 3.07M A ADS | 13Fas of Mar 31, 2026 |
Morgan StanleyInstitution | 3.08% | 1.35M A ADS · 1.35M A ADS · 1.35M A ADS | 13Fas of Mar 31, 2026 |
Barclays PLCInstitution | 2.58% | 1.13M A ADS · 1.13M A ADS · 1.13M A ADS | 13Fas of Mar 31, 2026 |
Citigroup IncInstitution | 2.37% | 1.04M A ADS · 1.04M A ADS · 1.04M A ADS | 13Fas of Mar 31, 2026 |
Kadensa Capital LtdInstitution | 1.69% | 737,949 A ADS · 737,949 A ADS · 737,949 A ADS | 13Fas of Mar 31, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings
Insider tradesForm 4
No open-market trades in the last 12 months.
Peers
Not reported.